Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/14/2003WO2003066672A1 Peptides
08/14/2003WO2003066666A2 Compositions and methods for treatment of vitamin d deficiency
08/14/2003WO2003066660A2 A PAIR OF ANTIBODY Fv FRAGMENTS STABILIZED BY COILED­COIL PEPTIDES
08/14/2003WO2003066652A2 Jlp cytoplasmic scaffolding protein and nucleic acids encoding it
08/14/2003WO2003066611A1 Bioluminescent protease assay
08/14/2003WO2003066098A2 Snares and methods of controlling cytokinesis
08/14/2003WO2003066097A2 A novel target to inhibit angiogenesis
08/14/2003WO2003066094A2 Hepatitis b vaccines
08/14/2003WO2003066093A1 A continuous cell line for the production of vaccines
08/14/2003WO2003066092A1 A method of producing and using heat shock proteins
08/14/2003WO2003066090A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003WO2003066089A1 Megsin ligands
08/14/2003WO2003066085A1 Albumin-fused anti-angiogenesis peptides
08/14/2003WO2003066079A2 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/14/2003WO2003066078A1 Hiv inhibiting proteins
08/14/2003WO2003066003A2 Anti-pathogen treatements
08/14/2003WO2003066002A2 IFN-a/b-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION
08/14/2003WO2003065999A2 Proliferated cell lines and uses thereof
08/14/2003WO2003065997A2 Anti-infarction molecules
08/14/2003WO2003065985A2 Uses of mammalian cytokine; related reagents
08/14/2003WO2003065977A2 Modified antigen-presenting cells
08/14/2003WO2003065973A2 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003WO2003065972A2 Methods for screening osteogenic compounds
08/14/2003WO2003065928A2 Therapeutic polyesters and polyamides
08/14/2003WO2003065873A2 Sga-1m, a cancer associated antigen, and uses thereof
08/14/2003WO2003065795A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances
08/14/2003WO2003050240A3 Expression system
08/14/2003WO2003048319A3 Nucleotide sequences encoding proteins conferring abiotic stress tolerance in plants
08/14/2003WO2003040352A9 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
08/14/2003WO2003039327A3 Methods and compositions for the diagnosis of cancer susceptibilities and defective dna repair mechanisms and treatment thereof
08/14/2003WO2003035845A3 Salvador tumor suppressor gene
08/14/2003WO2003032898A3 Modified human thymic stromal lymphopoietin
08/14/2003WO2003031575A3 A hybrid fusion protein transcription regulator to induce interferon target gene expression
08/14/2003WO2003031568A8 Intracellular signaling molecules
08/14/2003WO2003025201A3 Methods of using 5433, a human calcium channel family member
08/14/2003WO2003022995A3 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
08/14/2003WO2003020765A3 Vaccine therapies and prophylactic treatments of atherosclerotic diseases
08/14/2003WO2003018768A3 Transmembrane protein differentially expressed in cancer
08/14/2003WO2003014373A3 Metal-binding proteins
08/14/2003WO2003014303A3 Molecular interactions in cells
08/14/2003WO2002102849A3 Bcmp-101, a cancer associated protein
08/14/2003WO2002101048A3 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
08/14/2003WO2002099108A3 Atp-binding cassette transporter-like molecules and uses thereof
08/14/2003WO2002097115A3 Xrcc1 and uses thereof
08/14/2003WO2002083902A3 Adenovirus serotype 30 (ad30) fiber protein and uses thereof
08/14/2003WO2002079416A3 Transgenic animals resistant to transmissible spongiform encephalopathies
08/14/2003WO2002079241A3 Secreted streptococcus pneumoniae proteins
08/14/2003WO2002072803A3 Subgenomic replicons of the flavivirus dengue
08/14/2003WO2002070020A9 Polymer precursors of radiolabeled compounds, and methods of making and using the same
08/14/2003WO2002064632A3 Crystallized ppar$g(a) ligand binding domain polypeptide and screening methods employing same
08/14/2003WO2002064630A3 Il-1 receptor accessory protein
08/14/2003WO2002064620A3 Metal-binding compounds and uses therefor
08/14/2003WO2002059344A3 Gpr54 g protein-coupled receptor
08/14/2003WO2002058626A3 Methods and compositions for the identification and treatment of neurodegenerative disorders
08/14/2003WO2002057453A3 Polypetides and nucleic acids encoding same
08/14/2003WO2002057312A8 Fgfrl1 gene and protein encoded thereby
08/14/2003WO2002055657A3 Protein-protein interactions
08/14/2003WO2002051439A3 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
08/14/2003WO2002051438A3 Use of repulsive guidance molecule (rgm) and its modulators
08/14/2003WO2002050117A3 G-proteins coupled receptor proteins and nucleic acids encoding same
08/14/2003WO2002048342A3 Knockout mice for trp6 gene
08/14/2003WO2002048174A3 Dimeric fluorescent polypeptides
08/14/2003WO2002047718A3 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)
08/14/2003WO2002046415A3 Polynucleotide and polypeptide sequences of putative transporters and ion channells
08/14/2003WO2002042422A3 Molecular interactions in hematopoietic cells
08/14/2003WO2002039116A3 Retrovirus isolated from humans
08/14/2003WO2002038751A3 Ras/p21 transgenic mouse
08/14/2003WO2002038601A3 Foggy
08/14/2003WO2002036632A3 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides
08/14/2003WO2002034774A3 Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans
08/14/2003WO2002031130A9 Manipulation of soluble carbohydrates
08/14/2003WO2002029055A3 Carbohydrate-associated proteins
08/14/2003WO2002028420A3 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
08/14/2003WO2002026779A3 A fibrin/fibrinogen-binding conjugate
08/14/2003WO2002024887A3 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
08/14/2003WO2002024867A3 Novel compositions and methods for lymphoma and leukemia
08/14/2003WO2002024735A3 Peptide inhibitors of hiv entry
08/14/2003WO2002020788A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/14/2003WO2002020051A3 Equine infectious anemia challenge model for testing vaccines, diagnostics and treatments
08/14/2003WO2002016584A3 Process for the preparation of neutrophil inhibitory factor
08/14/2003WO2002014351A3 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES
08/14/2003WO2002012335A3 A NEW EGF MOTIF REPEAT PROTEIN OBTAINED FROM A cDNA LIBRARY FROM HS-5 STROMAL CELL LINE
08/14/2003WO2002008288A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003WO2002000705A3 Method and nucleic acids for the differentiation of astrocytoma, oligoastrocytoma and oligodendroglioma tumor cells
08/14/2003WO2001092527A3 Regulators of apoptosis
08/14/2003WO2001092292A3 Ghrelin analogs
08/14/2003WO2001090421A3 Method of detecting inflammatory lung disorders
08/14/2003WO2001090148A3 Neurotransmitter transporters
08/14/2003WO2001077176A3 E.coli blr molecules affecting antibiotic susceptibility
08/14/2003WO2001055198A9 Dermo- and gastro-specific sphingolipid activator
08/14/2003US20030154515 Triacylglycerol lipases
08/14/2003US20030154512 Sugar and lipid metabolism regulators in plants III
08/14/2003US20030154511 Plant retroviral polynucleotides and methods for use thereof
08/14/2003US20030154510 Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus
08/14/2003US20030154509 Control of gene expression in plants
08/14/2003US20030154508 Materials and methods for controlling pests
08/14/2003US20030154505 Transgenic non-human mammal with an oncogenic mutant of the c-Raf-1 gene
08/14/2003US20030154502 Universal markers of transgenesis
08/14/2003US20030154501 Analyzing effects of insecticides on gut of nematodes via high throughput assay
08/14/2003US20030154032 Methods and compositions for diagnosing and treating rheumatoid arthritis